BVMF/XRAY34 (BVMF/XRAY34)

Brazil Stock Exchange: BVMF/XRAY34 · BRL

R$43.0

+0.00 (0.0%)· Recorded snapshot

Market cap	10.1B
Revenue (ttm)	18.9B
Net income (ttm)	-2.8B
EPS (ttm)	-R$14.6
P/E (forward)	6.6x
Dividend	R$0.53 (1.24%)
Volume	0
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.9B
Net income (ttm): -2.8B
EPS (ttm): -R$14.6
P/E (forward): 6.6x
Market cap: 10.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E6.6

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-33

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/XRAY34 indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-05
Employees	14,000
Employees change	-1,000
Employees growth	-6.67%
Enterprise value	BRL 21.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1877
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRXRAYBDR005
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	BRL 10.1B
Next earnings date	2026-11-05
Price	BRL 43.00
Price currency	BRL
Sector	Healthcare
SIC code	3843
Stock price date	2026-10-14
Symbol	bvmf/XRAY34
Website	https://www.dentsplysirona.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-34%
EV/EBIT	22.43x
EV/EBITDA	6.53x
EV/FCF	28.79x
EV/Sales	1.09x
FCF / EV yield	3.47%
FCF yield	7.33%
Forward P/E	6.59x
P/(FCF - SBC) ratio	17.43x
P/(OCF - SBC) ratio	6.78x
P/B ratio	1.44x
P/FCF ratio	13.65x
P/OCF ratio	6.12x
P/S ratio	0.54x
Price/EBITDA ratio	3.71x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.86%
EBITDA margin	14.44%
FCF margin	3.8%
Gross margin	49.52%
Operating margin	4.86%
Pretax margin	-9.53%
Profit margin	-14.99%
Profit per employee	BRL -202,051
Profitable quarters	1
Revenue per employee	BRL 1.3M
ROA	1.96%
ROA (5Y)	2.82%
ROCE	4.4%
ROE	-33.03%
ROE (5Y)	-17.64%
ROIC	5.12%
ROIC (5Y)	5.86%
SBC / revenue	0.85%
Tax / revenue	5.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
FCF growth	3.62%
FCF growth (Q)	243.75%
FCF growth 3Y	-10.28%
FCF growth 5Y	-25.76%
Gross profit growth	-5.35%
Gross profit growth (Q)	0.61%
Gross profit growth 3Y	-4.91%
Gross profit growth 5Y	-4.15%
Net income growth quarters	1
Net income growth years	1
OCF growth	12.72%
OCF growth (Q)	106.25%
OCF growth (QoQ)	147.5%
OCF growth 10Y	-3.89%
OCF growth 3Y	-1.52%
OCF growth 5Y	-15.67%
Operating income growth	-37.23%
Operating income growth (Q)	-23.85%
Operating income growth 3Y	-13.97%
Operating income growth 5Y	-22.13%
Revenue growth	-0.76%
Revenue growth (Q)	-4.06%
Revenue growth (QoQ)	2.05%
Revenue growth 10Y	1.58%
Revenue growth 3Y	-2.55%
Revenue growth 5Y	-2.15%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -911.8M
Depreciation and amortization	BRL 1.9B
EBIT	BRL 917M
EBITDA	BRL 2.7B
EPS	BRL -14.62
Financing cash flow	BRL -1.4B
Free cash flow	BRL 740.9M
Free cash flow minus SBC	BRL 580.2M
Gross profit	BRL 9.3B
Income taxes	BRL 1B
Investing cash flow	BRL -896.3M
Net borrowing	BRL -780.7M
Net cash flow	BRL -621.7M
Net income	BRL -2.8B
Operating cash flow minus SBC	BRL 1.5B
Operating income	BRL 917M
Revenue	BRL 18.9B
Stock-based compensation	BRL 160.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.96
Book value per share	BRL 35.14
Debt / EBITDA	3.83
Debt / equity	1.72
Debt / FCF	16.27
Goodwill	BRL 6.1B
Interest coverage	1.7
Long-term assets	BRL 16.7B
Long-term liabilities	BRL 13.6B
Net cash (debt)	BRL -10.8B
Net cash / market cap	-106.98%
Net debt / EBITDA	3.97
Net debt / equity	1.55
Net debt / FCF	14.6
Piotroski F-Score	5
Property, plant and equipment	BRL 5.2B
Shareholders' equity	BRL 7B
Tangible book value	BRL -3.4B
Tangible book value per share	BRL -17.09
Total assets	BRL 27B
Total cash	BRL 1.2B
Total debt	BRL 12.1B
Total liabilities	BRL 20B
WACC	6.06%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	BRL 10.3B
Current liabilities	BRL 6.3B
Current ratio	1.63
Inventory turnover	2.74
Net working capital	BRL 3.8B
Quick ratio	0.72
Working capital	BRL 3.8B
Working capital turnover	24.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.08%
Dividend growth	-0.69%
Dividend growth (3Y)	9.17%
Dividend growth (5Y)	9.63%
Dividend growth years	0
Dividend payment date	2026-01-15
Dividend payment years	7
Dividend per share	BRL 0.53
Dividend yield	1.24%
Ex-dividend date	2025-12-23
Last dividend	BRL 0.11
Shareholder yield	1.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	-23.21%
1M total return	-23.21%
1W price change	-0.35%
1W total return	-0.35%
1Y price change	-35.44%
1Y return CAGR	-34.85%
1Y total return	-34.84%
20-day SMA	BRL 57.21
3M price change	-27.12%
3M total return	-27.12%
3Y price change	-74.27%
3Y return CAGR	-35.37%
3Y total return	-73.01%
50-day SMA	BRL 64.12
52-week high	BRL 74.08
52-week high date	2026-02-27
52-week low	BRL 42.30
52-week low date	2026-10-05
6M price change	-27.73%
6M total return	-27.73%
All-time high	BRL 364.80
All-time high date	2021-04-23
All-time low	BRL 42.30
All-time low date	2026-10-05
Average true range (ATR)	BRL 3.05
Average volume	644.5
Beta (5Y)	0.88
Change from 52-week high	-41.95%
Change from 52-week low	1.66%
Change from all-time high	-88.21%
Change from all-time low	1.65%
Change from open	0%
Day's gap	0%
High price	BRL 43.00
Low price	BRL 43.00
Monthly RSI	31.43
Open price	BRL 43.00
Previous close	BRL 43.00
Price vs 20-day SMA	-24.84%
Price vs 50-day SMA	-32.94%
Relative volume	0
RSI	27.36
Sharpe ratio	-1.23
Sortino ratio	-1.53
Volume	0
Weekly RSI	29.12
YTD price change	-31.88%
YTD total return	-31.24%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	187.9M
Shares change (QoQ)	0.3%
Shares change (YoY)	0.08%
Shares held by insiders	0.49%
Shares held by institutions	109.75%
Short ratio	6.5 days

Deeper analysis on BVMF/XRAY34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/XRAY34 report

Is a complete BVMF/XRAY34 research report available?

No complete published report is available for bvmf/XRAY34 (BVMF/XRAY34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/XRAY34 (BVMF/XRAY34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/XRAY34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/XRAY34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/XRAY34

Frequently asked questions